tirzepatide menu plan Meal 30-Day Semaglutide & Tirzepatide Meal

Work with your provider to find strategies to manage common side effects

The multi-pathway approach aims to mimic the body's natural metabolic regulation more closely

Tirzepatide and Semaglutide weight loss injections are administered as a subcutaneous injection once a week

FDA Boxed Warning: Risk of Thyroid C-Cell Tumors In line with all other GLP-1 receptor agonist therapies, Tirzepatide carries a boxed warning regarding the risk of thyroid C-cell tumors, including the rare but serious cancer, medullary thyroid carcinoma (MTC)

Retrieved from Tchang, B

The appropriate pathway depends on clinician judgment, patient-specific medical factors, insurance coverage, regulatory status, and out-of-pocket cost